Neat descriptions & photos for itchy travel bug.

https://www.telegraph.co.uk/travel/activity-and-adventure/the-last-unexplored-places-on-earth/?WT.mc_id=tmg_share_tw

Want to discover a new species, tread where others haven’t, or simply leave behind the stresses of the modern world? These destinations are a good place to start.

might not be CNBC but ick! HMNY RS & 4x share size

MG just read your GE comment. Darn thing was a cult trap. Had an otherwise smart lady friend buy into it after fell from 30 to 22. Couldn't resist or see the light since she'd once worked there and was in love with the past. Sad. Tried to warn her, but. She also picked up some SNAP and holding it for a FB type play. Told her to sell it when up a $1 but no go. Bot at IPO day & wouldn't take the buck plus. So it goes. GO YANKS

Hi MG. Been busy with things. Hope can get a good feel for this funny market lately. Spec things not helping the picture.

HMNY H&M parent of MoviePass seeks R/S & 4x shares from 500M to 2Bln

True OTC penny stock behavior in a Nasdaq play. At least they've kissed the death rather than hang fire like a SNAP.
Odds they pick the high side 1-250? I mean really, 1-2 to 1-250 lol

MoviePass Parent Stock Plunges on Stock Issuance, Potential Reverse Split -- Market Talk
Today 7:08 PM ET (Dow Jones)Print
1855 EDT [Dow Jones] -- Shares in Helios & Matheson Analytics Inc. fell 31% in after-hours trading after the parent company of MoviePass said it would hold a special shareholder meeting in July to quadruple its number of shares to 2 billion from 500 million. The company said it needed the additional shares in part to issue to a financier as part of a transaction that could bring it up to $35 million in much-needed capital. Helios is also asking shareholders to authorize a reverse stock split at a ratio of between 1-to-2 and 1-to-250. Its shares have been trading below $1 since May 9 and could be delisted from the Nasdaq under a rule requiring that traded stocks be worth more than $1 each. Helios shares closed up 27% at 45 cents Tuesday before a regulatory filing about the special meeting was made public. (ben.fritz@wsj.com)

(END) Dow Jones Newswires

June 19, 2018 19:08 ET (23:08 GMT)

HMNY H&M parent of MoviePass seeks R/S & 4x shares from 500M to 2Bln

True OTC penny stock behavior in a Nasdaq play. At least they've kissed the death rather than hang fire like a SNAP.
Odds they pick the high side 1-250? I mean really, 1-2 to 1-250 lol

MoviePass Parent Stock Plunges on Stock Issuance, Potential Reverse Split -- Market Talk
Today 7:08 PM ET (Dow Jones)Print
1855 EDT [Dow Jones] -- Shares in Helios & Matheson Analytics Inc. fell 31% in after-hours trading after the parent company of MoviePass said it would hold a special shareholder meeting in July to quadruple its number of shares to 2 billion from 500 million. The company said it needed the additional shares in part to issue to a financier as part of a transaction that could bring it up to $35 million in much-needed capital. Helios is also asking shareholders to authorize a reverse stock split at a ratio of between 1-to-2 and 1-to-250. Its shares have been trading below $1 since May 9 and could be delisted from the Nasdaq under a rule requiring that traded stocks be worth more than $1 each. Helios shares closed up 27% at 45 cents Tuesday before a regulatory filing about the special meeting was made public. (ben.fritz@wsj.com)

(END) Dow Jones Newswires

June 19, 2018 19:08 ET (23:08 GMT)

FSSN came off floor in week .08 to .24

Thanks MG!

TXMD run pause. 7.25 earlies ENDP IMTE

TherapeuticsMD Announces Multiple Presentations at the International Menopause Society’s 16th World Congress

ANW AXON CANN DPW early cheaps. SIG too

careful these are new to me. Sometimes early ones flame out by Noon ET

AF I'm public only. No biggie. I'll just avoid charts. em

AF is this the chart template ok? $RIOT

Thanks for post Agusta. I get pretty busy so tricky to get handle on these things. I plugged RIOT into the link you sent with chart for BDR before,

RIOT not something I usually mess with given the recent news. But had followers and it's a guess that should crypos catch a wave again it could have some room. There's bunch of resist above.

http://stockcharts.com/h-sc/ui?s=RIOT&p=D&yr=0&mn=3&dy=0&id=p11960084343

Can't seem to capture image from stockcharts tho. Been while since I've done this.

$PBIO weaky $BLPH rangy

On a day chart PBIO looks like fell < medium term support and out of the narrow range box it had for while 3.25 / 4 now 2.87
Way it fell looks like buyers stepped away rather than a short attack.
Me, I'd wait for $0.50 > support to prove itself.

$BLPH had some followers fuss with it other day. Needs news to break its range box.

CWBR 8.22 poked head > resist again 8.12 +1.02
Pushing the 7.95 - 8.22 candle.

It tried @ 11am et to > 8.10 I used to like these ones that keep reacting upside after a pop & sag. Beats pop & stay drop.
No DD after late May report & to Present CohBar to Present CB4211 Novel Mechanism of Action at American Diabetes Association 78th Scientific Sessions

DCPH bit chop along top after am run 36.38 +40%

some cheaper moves holding flat at least GEVO RSLS old FRED.

maybe more in AVXL BDR AETI CWBR
chop in EOLS GLMD

Wow MG that's some travel NJ to LI

Man I thought just goring from W 70s NYC to Far Rockaway on subway for a babe was ordeal. She and her crowd had run of a big basement so fun times. But killer rides. Commack yes just so banal. Hobo had its day.
I did W 16 & E 18 lofts. Sort of miss them but lousy landlords for an artist, lol. Happy nuf in Hell's Kitchen for long time and Hudson Yards has brought the High Line energy along with massive rebuilding along Eleven Ave. Hudson River Park is nice overlooking Hobo NJ coast. Both sides are a total nuther world now.
Liked North Mia and even downtown. Had use of a small outdoor pool in shaded area off Bis Bay Blvd. Prob a mega tower by now. The Grove was nice too. That was just before Miami Vice days & the arty rebuild.
As can tell dividing time between art & market now that have an Upper East Side gallery rep. Foothold helps. Now I'm the old-timer looking at the kids and wondering what awaits them. Long way from Ford to City, Drop Dead
Took an outside force to produce the kick in the ass the place needed. Horrible way to fire a place up but has happened before and likely again.
Hangs on those, like a SNAP..... Check ya later MG oh ain't dental work a real rough one! Bones, muscles and teeth. Time for some stem bio breakthroughs. Enough with the pain, and recoveries way too long.

Hey MG nice list, bugs aside.

Lot of those places rumored to have big fat old bugs, lol.

Personal choices are lower down, yet high up in some cases.
Blue Ridge Mtns. Some parts of upstate NY like Woodstock & Bear Mountain.

Flatter areas nice in summer Mid Penna. North Fork L.I.

DIGX dang hangs 4-5 forever

This old fave hasn't had a pop to .001 for long while now. Just had to give it a mention. Nothing yet on horizon. If can get for 3 worth spec.
Not much else, SANP stays alive but quiet too. PZOO but that fat OS ?

Cramer was all giddy on MSFT pre open fwiw. CNBC next

CNBC is interviewing the MS head wig upcoming this am - soonish

some early pops, these often fade by Noon tho

TROV gap VSAR pop & dip HPJ same CNET too & ATIS have to check later to see if more enduring ones.

Hi HYS. nice chart here, quiet day start

Like the recent climb. Bit thin for my taste in volume. We'll see. Thanks added following U. g/l

Thanks T-S. super busy w/ side things.

Hope I can get to board bit more. I tend to mushroom in summer though.
Stay cool & well & rich nuf.

Credit Suisse R/S 1-10 VIIZ & TVIX ETNs 6.8.2018

TVIX 3/16/17 did R/S @ same size with a 1/25 before that one. Total
of 5 before this one.

https://finance.yahoo.com/news/credit-suisse-ag-announces-reverse-123000050.html?.tsrc=rss

NEW YORK, May 31, 2018 /PRNewswire/ -- Credit Suisse AG announced today that it will implement a 1-for-10 reverse split of its VelocityShares™ VIX Medium Term ETNs ("VIIZ") and a 1-for-10 reverse split of its VelocityShares™ Daily 2x VIX Short Term ETNs ("TVIX"), each expected to be effective as of June 8, 2018.

Credit Suisse logo. (PRNewsFoto/Credit Suisse)

The reverse splits will be effective at the open of trading on June 8, 2018. VIIZ and TVIX will each begin trading on the Nasdaq Stock Market on a reverse split-adjusted basis on June 8, 2018. Holders of VIIZ and TVIX who purchased such ETNs prior to June 8, 2018 will receive one reverse split-adjusted ETN for every ten pre-reverse split ETNs, respectively.

In addition, such purchasers that hold a number of ETNs not evenly divisible by ten will receive a cash payment for any fractional ETNs remaining (the "partials"). The cash amount due on any partials will be determined on June 14, 2018 based on the respective closing indicative values of VIIZ and TVIX on such date and will be paid by Credit Suisse AG on or about June 19, 2018.

The closing indicative values of VIIZ and TVIX on June 7, 2018 will be multiplied by ten to determine their respective reverse split-adjusted closing indicative values. Following the reverse splits, VIIZ and TVIX will have new CUSIPs but will retain their same ticker symbols.

The reverse splits will affect the trading denominations of VIIZ and TVIX but they will not have any effect on the stated principal amount of any ETN, except that the stated principal amount of each will be reduced by the corresponding aggregate amount of any cash payments for the "partials."

Illustration of a Reverse Split

The following table shows the effect of a 1-for-10 reverse split on 100,000 ETNs:


Number of

ETNs

Hypothetical Closing

Indicative Value

Aggregate Closing

Indicative Value

Pre-Reverse Split

100,000

$5.00

$500,000

1-for-10 Post-Reverse Split

10,000

$50.00

$500,000

The above table illustrates the effect of the reverse split on the number of ETNs and the hypothetical closing indicative value of the ETNs. The closing indicative value is not the same as the trading price of the ETNs.

None of the other exchange traded notes issued by Credit Suisse AG are affected by this announcement.

Credit Suisse R/S 1-10 VIIZ & TVIX 6.8.2018

https://finance.yahoo.com/news/credit-suisse-ag-announces-reverse-123000050.html?.tsrc=rss

NEW YORK, May 31, 2018 /PRNewswire/ -- Credit Suisse AG announced today that it will implement a 1-for-10 reverse split of its VelocityShares™ VIX Medium Term ETNs ("VIIZ") and a 1-for-10 reverse split of its VelocityShares™ Daily 2x VIX Short Term ETNs ("TVIX"), each expected to be effective as of June 8, 2018.

Credit Suisse logo. (PRNewsFoto/Credit Suisse)

The reverse splits will be effective at the open of trading on June 8, 2018. VIIZ and TVIX will each begin trading on the Nasdaq Stock Market on a reverse split-adjusted basis on June 8, 2018. Holders of VIIZ and TVIX who purchased such ETNs prior to June 8, 2018 will receive one reverse split-adjusted ETN for every ten pre-reverse split ETNs, respectively.

In addition, such purchasers that hold a number of ETNs not evenly divisible by ten will receive a cash payment for any fractional ETNs remaining (the "partials"). The cash amount due on any partials will be determined on June 14, 2018 based on the respective closing indicative values of VIIZ and TVIX on such date and will be paid by Credit Suisse AG on or about June 19, 2018.

The closing indicative values of VIIZ and TVIX on June 7, 2018 will be multiplied by ten to determine their respective reverse split-adjusted closing indicative values. Following the reverse splits, VIIZ and TVIX will have new CUSIPs but will retain their same ticker symbols.

The reverse splits will affect the trading denominations of VIIZ and TVIX but they will not have any effect on the stated principal amount of any ETN, except that the stated principal amount of each will be reduced by the corresponding aggregate amount of any cash payments for the "partials."

Illustration of a Reverse Split

The following table shows the effect of a 1-for-10 reverse split on 100,000 ETNs:


Number of

ETNs

Hypothetical Closing

Indicative Value

Aggregate Closing

Indicative Value

Pre-Reverse Split

100,000

$5.00

$500,000

1-for-10 Post-Reverse Split

10,000

$50.00

$500,000

The above table illustrates the effect of the reverse split on the number of ETNs and the hypothetical closing indicative value of the ETNs. The closing indicative value is not the same as the trading price of the ETNs.

None of the other exchange traded notes issued by Credit Suisse AG are affected by this announcement.

Credit Suisse R/S 1-10 VIIZ & TVIX 6.8.2018

https://finance.yahoo.com/news/credit-suisse-ag-announces-reverse-123000050.html?.tsrc=rss

NEW YORK, May 31, 2018 /PRNewswire/ -- Credit Suisse AG announced today that it will implement a 1-for-10 reverse split of its VelocityShares™ VIX Medium Term ETNs ("VIIZ") and a 1-for-10 reverse split of its VelocityShares™ Daily 2x VIX Short Term ETNs ("TVIX"), each expected to be effective as of June 8, 2018.

Credit Suisse logo. (PRNewsFoto/Credit Suisse)

The reverse splits will be effective at the open of trading on June 8, 2018. VIIZ and TVIX will each begin trading on the Nasdaq Stock Market on a reverse split-adjusted basis on June 8, 2018. Holders of VIIZ and TVIX who purchased such ETNs prior to June 8, 2018 will receive one reverse split-adjusted ETN for every ten pre-reverse split ETNs, respectively.

In addition, such purchasers that hold a number of ETNs not evenly divisible by ten will receive a cash payment for any fractional ETNs remaining (the "partials"). The cash amount due on any partials will be determined on June 14, 2018 based on the respective closing indicative values of VIIZ and TVIX on such date and will be paid by Credit Suisse AG on or about June 19, 2018.

The closing indicative values of VIIZ and TVIX on June 7, 2018 will be multiplied by ten to determine their respective reverse split-adjusted closing indicative values. Following the reverse splits, VIIZ and TVIX will have new CUSIPs but will retain their same ticker symbols.

The reverse splits will affect the trading denominations of VIIZ and TVIX but they will not have any effect on the stated principal amount of any ETN, except that the stated principal amount of each will be reduced by the corresponding aggregate amount of any cash payments for the "partials."

Illustration of a Reverse Split

The following table shows the effect of a 1-for-10 reverse split on 100,000 ETNs:


Number of

ETNs

Hypothetical Closing

Indicative Value

Aggregate Closing

Indicative Value

Pre-Reverse Split

100,000

$5.00

$500,000

1-for-10 Post-Reverse Split

10,000

$50.00

$500,000

The above table illustrates the effect of the reverse split on the number of ETNs and the hypothetical closing indicative value of the ETNs. The closing indicative value is not the same as the trading price of the ETNs.

None of the other exchange traded notes issued by Credit Suisse AG are affected by this announcement.

Big Public Offer hitting it pre-Open

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer, today announced the pricing of an underwritten public offering with gross proceeds of approximately $18,000,000, before deducting underwriting discounts, commissions and other offering expenses. The offering consists of: (i) 3,000,000 shares of our Common Stock together with a number of Common Warrants to purchase 1,500,000 shares of our Common Stock, and (ii) 9,500,000 Pre-funded Warrants, with each Pre-funded Warrant exercisable for one share of Common Stock, together with a number of Common Warrants to purchase 4,750,000 shares of our Common Stock. The Common Warrants will have an exercise price of $1.584, will be exercisable upon issuance and will expire five years from the date of issuance. Heat Biologics, Inc. has granted the underwriters a 45-day option to purchase up to an additional 1,875,000 shares of Common Stock and/or 937,500 Common Warrants to cover over-allotments if any. The offering is expected to close on May 7, 2018, subject to customary closing conditions.

A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, Inc., is acting as the sole book-running manager for the offering.

CIM Securities, LLC is acting as a Co-Manager for the offering.

$HTBX (-48.0% pre) Heat Biologics Prices $18 Million Public Offering - SI

Heat Biologics, Inc. ("Heat") (NASDAQ: HTBX), a biopharmaceutical company developing drugs designed to activate a patient's immune system against cancer, today announced the pricing of an underwritten public offering with gross proceeds of approximately $18,000,000, before deducting underwriting discounts, commissions and other offering expenses. The offering consists of: (i) 3,000,000 shares of our Common Stock together with a number of Common Warrants to purchase 1,500,000 shares of our Common Stock, and (ii) 9,500,000 Pre-funded Warrants, with each Pre-funded Warrant exercisable for one share of Common Stock, together with a number of Common Warrants to purchase 4,750,000 shares of our Common Stock. The Common Warrants will have an exercise price of $1.584, will be exercisable upon issuance and will expire five years from the date of issuance. Heat Biologics, Inc. has granted the underwriters a 45-day option to purchase up to an additional 1,875,000 shares of Common Stock and/or 937,500 Common Warrants to cover over-allotments if any. The offering is expected to close on May 7, 2018, subject to customary closing conditions.

A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, Inc., is acting as the sole book-running manager for the offering.

CIM Securities, LLC is acting as a Co-Manager for the offering.

Energy up pre /CL 63.25 +1.12 em

FISV pre +1.2% on F/S 2-1 effective

Fiserv's stock gains after stock split goes into effect
Today 9:04 AM ET (MarketWatch)
t
Fiserv Inc.'s stock price (FISV) has been adjusted to reflect a 2-for-1 stock split (http://www.marketwatch.com/story/financial-services-tech-company-fiserv-announces-2-for-1-stock-split-2018-02-22), which went into effect after Monday's close. The financial services technology company's stock closed Monday at a pre-split price of $147.24, which would be the equivalent of a post-split price of $73.62. The stock was changing hands about 1.2% above that price in premarket trade Tuesday. The last stock split, also a 2-for-1 split, occurred on Dec. 17, 2013. The stock, which reached a record pre-split close of $148.44 on March 16, has rallied 26.2% over the past 12 months, while the S&P 500 has gained 14.3%.

-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

March 20, 2018 09:04 ET (13:04 GMT)

EARS R/S 1-10 today 1.551 +1.30 Auris Medical Holding
didn't see this until while ago

Stock Split in General
Auris Medical Holding AG EARS:NASDAQ
Auris Medical Holding AG has announced a 1-10 split effective 3/14/18.

EARS R/S 1-10 today 1.551 +1.30 Auris Medical Holding

Stock Split in General
Auris Medical Holding AG EARS:NASDAQ
Auris Medical Holding AG has announced a 1-10 split effective 3/14/18.

TENX R/S Feb. 26 1-20 Nas comply
08:23 AM EST, 02/23/2018 (MT Newswires) -- Tenax Therapeutics (TENX), a specialty pharmaceutical company, said Friday it will implement a reverse stock split of its shares of common stock at a ratio of 1-for-20 that will take effect Feb. 26. The reverse stock split was approved by stockholders and the board of directors on Feb. 15.
In September, Tenax received a notice from Nasdaq granting the company an additional 180 calendar days, or until March 12, to regain compliance with the minimum $1.00 bid price per share requirement. The reverse stock split is intended to increase the market price per share to help ensure a share price high enough to satisfy the minimum bid price requirement.
As a result of the reverse stock split, every 20 shares of Tenax's common stock issued and outstanding on the effective date will be combined into one issued and outstanding share, with no change in the nominal par value per share of $0.0001.
http://www.mtnewswires.com

PMTS Chip card maker RS 1-5 to keep listing

Looks like $3.50 AH after $4+ start

https://www.bizjournals.com/newyork/news/2017/12/20/colorado-chip-card-maker-in-reverse-stock-split-to.html?ana=e_ae_set3&s=article_du&ed=2017-12-20&u=HKARBC5svmwcB8wjSe2DlA0a1200b3&t=1513805590&j=79373351


CPI Card Group Inc.

By Ben Miller – Contributing Writer
2 hours ago
CPI Card Group Inc. said it effected a five-for-one reverse stock split Wednesday in an effort to have its shares remain on the Nasdaq stock exchange.

The Littleton maker of chip-enabled credit cards (Nasdaq: PMTS) said in a statement that "the reverse stock split is primarily intended to bring the company into compliance with the minimum bid price requirement for maintaining its listing on the Nasdaq Global Select Market."

The Nasdaq exchange generally requires stock prices to stay above $1-per-share; prior to Wednesday's reverse stock split, CPI Card Group's shares hadn't traded above $1 since early November. On Wednesday, after the reverse stock split, its shares opened at $4.

The company's been battling some headwinds: In November, it reported third-quarter sales fell by 20 percent, dropping to $39.3 million.

Also in November, the company said it will no longer provide future guidance about its earnings and revenues, saying "it is prudent to take the time to review and assess the business, enhance our strategies and execute our key initiatives."

COTE R/S 1-200 COTEd.pk on Mon. 12/4

1 RS it seems. Fat AS & OS.

WALL TOWNSHIP, N.J. , Dec. 01, 2017 (GLOBE NEWSWIRE) -- Coates International, Ltd. (OTC PINK:COTE) (the “Company”). The Company’s board of directors set a reverse stock split ratio of 1 new post-split share of common stock for each 200 shares of pre-split common stock (a 1:200 ratio) to become effective at the close of trading on December 1, 2017 . The reverse stock split was originally authorized and announced in an information statement on Schedule 14(c) filed with the Securities Exchange Commission and a mailing to shareholders of record in March 2015 . As of the opening of trading on December 4, 2017 , the trading price per share will be adjusted to reflect the reverse stock split and the Company’s ticker symbol will begin trading as COTED to designate that it is trading under dividend status for twenty consecutive trading days, after which the ticker symbol will revert back to COTE. The CUSIP number of the post-split shares is 190643205.
Shareholders will receive a detailed communication from American Stock Transfer & Trust , the Company’s stock transfer agent explaining how the share exchange will occur. Anyone holding shares of the Company’s common stock in paper certificate form must submit the old certificates to American Stock Transfer & Trust in order to obtain new, post-split shares. Pre-split shares in certificate form will no longer be able to be sold or transferred; they may only be exchanged for new post-split shares. Any resulting fractional shares will be paid for in cash by the Company based on the closing trading price per share on December 1, 2017 .
Management expects that the reverse stock split will result in an increase in the trading price of the common stock, which may reduce costs and facilitate the process for trading in our shares.
There can be no assurance that the Company will be successful in any of its endeavors.
Safe Harbor Statement:
This press release contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Please see our filings with the Securities and Exchange Commission . Our public filings with the SEC may be viewed and printed on the website maintained by the SEC at http://www.sec.gov.
Contact Information:

Coates International , Ltd.Phone: 732-449-7717Fax:
732-449-0764www.coatesengine.comwww.mostadvancedengine.com

Source: Coates International

CYTR did 1-6 yesterday Nasdaq

CytRx Corporation Announces Reverse Stock Split

9:00 am ET October 31, 2017 (PR Newswire) Print
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced the previously disclosed 1-for-6 reverse stock split of its issued and outstanding common stock will become effective as of the commencement of trading on Wednesday, November 1, 2017 (the "Effective Time"). The split-adjusted shares of CytRx's common stock will continue trading on the Nasdaq Capital Market under the Company's existing symbol "CYTR." A new CUSIP number of 232828608 has been assigned to the Company's common stock as a result of the reverse split.

The reverse stock split will reduce the number of shares of common shares outstanding from approximately 165.8 million to approximately 27.6 million upon commencement of trading on the Effective Date. Authorized shares will also be proportionally reduced from 250 million to approximately 41.7 million, and the preferred stock will be reduced from 5 million shares to approximately 0.8 million shares. The reverse stock split affects all issued and outstanding shares of the Company's Common Stock immediately prior to the Effective Time of the reverse stock split.

At a Special Meeting of Stockholders held on October 27, 2017, the Company's stockholders approved a proposal authorizing the Company to amend its certificate of incorporation and enact a 1-for-6 reverse stock split of the Company's issued and outstanding shares.

American Stock Transfer and Trust Company, CytRx's transfer agent, will instruct certificate shareholders on the exchange process once the reverse stock split takes effect. Shareholders holding their shares in book-entry form or in brokerage accounts need not take any action in connection with the reverse stock split. Beneficial holders are encouraged to contact their bank, broker or custodian with any procedural questions. No fractional shares will be issued. Stockholders who otherwise would be entitled to receive fractional shares because they hold a number of shares not evenly divisible by 6, will automatically receive one whole share of Common Stock in lieu of the fractional share.

About CytRx Corporation

CytRx Corporation is a biopharmaceutical company specializing in research and clinical development of novel anti-cancer drug candidates that employ linker technologies to enhance the accumulation and release of drug at the tumor. Aldoxorubicin, CytRx's most advanced drug conjugate, is an improved version of the widely used chemotherapeutic agent doxorubicin and has been out-licensed to NantCell, Inc. CytRx is also rapidly expanding its pipeline of ultra-high potency oncology candidates at its laboratory facilities in Freiburg, Germany, through its LADR(TM) (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage CytRx's expertise in albumin biology and linker technology for the development of a new class of potential breakthrough anti-cancer therapies.

thx bb been tracking QBAN_toid

Showed up on a scanner past week or two.
.0005 -0.0003 day w/ some block trades on scanner.
183M on hvy volume

Hey back ya TS

Thanks for heads up. Laying low as things got so hot. Baltic Dry Index on bit of a roll finally - but just upper end so far like ones >$5.
The low downs look set for folding, merging.

DVBT took some hit on P3 fail while opponent ran. Small pop off lod.

EXAC & PETS ok. DVA STM WDC SM watching be good & careful

Thx MG will save for next summer

Upstate NY is quite nice. Spent little time in Syracuse and more @Hudson Valley. Pretty busy in Man'h to get away but this is a nice reminder to get on the Expressway & 9W.

BZ: TOP Ships Receives NASDAQ Delisting Notice 4:30pm ET em

CHFS R/S 1-20 news today for tomorrow. $0.531
12:55pm ET
EDEN PRAIRIE, Minn. , Oct. 12, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today a 1-for-20 reverse split of its common stock, effective at 5:00 pm Eastern time today. Beginning tomorrow, October 13, 2017 , the Company’s common stock will trade on The Nasdaq Capital Market on a split adjusted basis.
At CHF Solutions’ special meeting of stockholders on October 10, 2017 , the Company’s stockholders authorized the Board of Directors to amend the Fourth Amended and Restated Certificate of Incorporation, as amended, of the Company to effect a reverse stock split at a ratio in the range of 1-for-10 to 1-for-20, as determined at the discretion of the Company’s Board of Directors.
Upon effectiveness, the reverse stock split will cause a reduction in the number of shares of common stock outstanding and issuable upon the conversion of the Company’s outstanding stock options and warrants in proportion to the ratio of the reverse split, and will cause a proportionate increase in the conversion and exercise prices of such stock options and warrants. The number of shares of common stock issuable upon the exercise or vesting of outstanding stock options and warrants will be rounded down to the nearest whole share.
The Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “CHFS.” The new CUSIP number for the common stock following the reverse split is 12542Q 508.
The number of authorized shares of the Company’s common stock will remain at 100,000,000, while the number of outstanding shares will be reduced from approximately 12.5 million to approximately 626,000. No fractional shares will be issued following the reverse stock split.
Additional information about the reverse stock split can be found in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on September 8, 2017 , a copy of which is also available on the Company’s website under the Investors page.
About CHF Solutions
CHF Solutions, Inc. (NASDAQ:CHFS) is a medical device company focused on commercializing the Aquadex FlexFlow system for Aquapheresis® therapy. The Aquadex FlexFlow system, is indicated for temporary (up to eight hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended (longer than 8 hours) ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. All treatments must be administered by a healthcare provider, under physician prescription, both of whom having received training in extracorporeal therapies. The company's objective is to improve the quality of life for patients with heart failure and related conditions. CHF Solutions is a Delaware corporation headquartered in Minneapolis with wholly owned subsidiaries in Australia and Ireland . The company has been listed on the NASDAQ Capital Market since February 2012 .
For further information, please contact:
Claudia Napal Drayton
Chief Financial Officer
CHF Solutions Inc.
T: +1-952-345-4205

Investor Relations:
CHF Solutions, Inc.
ir@chf-solutions.com

-or-

Bret Shapiro
Managing Partner
CORE IR
516 222 2560
brets@coreir.com
www.coreir.com

Image: Primary Logo


Source: CHF Soluti

IFON InfoSonics R/S 1-5 today

Stock Split in General
InfoSonics Corp IFON:NASDAQ
InfoSonics Corp has announced a 1-5 split effective 10/11/17.

6 7 8 on ask now 6 7 em

EDU PINC AMC SAVE UNIT nice goers em